FDA Adverse Event Injury Summary report: N

ASR UNI FEMORAL IMPL SIZE 53

MDR report key: 4112390 · Received September 23, 2014

Report

Report Number
1818910-2014-28721
Event Type
Injury
Date Received
September 23, 2014
Date of Event
September 4, 2014
Report Date
February 16, 2015
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KWA
PMA / PMN Number
PK040627
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED.

Additional Manufacturer Narrative · 1

IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.DEPUY STILL CONSIDERS THIS INVESTIGATION CLOSED.

Description of Event or Problem · 1

UPDATE REC'D 02/16/2015- LITIGATION PAPERS RECEIVED. LITIGATION ALLEGES PAIN, GRINDING, CLICKING, POPPING, DIFFICULTY WALKING, INSTABILITY, INFECTION, DISABILITY, DISFIGUREMENT, AND ELEVATED METAL ION LEVELS. THE DOB WAS PROVIDED. THE STEM IS BEING ADDED TO THE COMPLAINT DUE TO ELEVATED METAL ION LEVELS BEING REPORTED. THE COMPLAINT WAS UPDATED ON: 02/24/2015.

Description of Event or Problem · 1

SALES REP REPORTED REVISION SURGERY. PATIENT HAS BEEN REVISED TO ADDRESS PAIN.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
589834 ASR UNI FEMORAL IMPL SIZE 53 HIP FEMORAL HEAD KWA DEPUY INTL., LTD. - 8010379 2728558

Patients

Seq Age Sex Outcome Treatment
1 89 YR Required Intervention